ROSIGLITAZONE相关论文
The Activation of Peroxisome Proliferator-activated Receptor γ Enhances Insulin Signaling Pathways V
...
Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor γ a
...
Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2
...
...
Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty aci
...
目的 研究抵抗素在过氧化物酶增殖物激活受体(PPAR-γ)激动剂(罗格列酮)对大鼠重症急性胰腺炎(SAP)及其合并肺损伤防治中的作用及......
目的 探讨罗格列酮对老年原发性高血压合并2型糖尿病患者血压的影响.方法 选择住院的原发性高血压合并2型糖尿病患者62例,采用随机......
目的 观察罗格列酮联合炔雌醇环丙孕酮对伴有胰岛素抵抗的多囊卵巢综合征(PCOS)患者的治疗效果.方法 选择伴有胰岛素抵抗的PCOS患......
罗格列酮和吡格列酮同属为噻唑烷二酮类胰岛素增敏剂,主要用于2型糖尿病的治疗。罗格列酮因可能增加心血管事件风险于2010年被限用......
目的 观察罗格列酮对高糖培养基中大鼠系膜细胞活性氧(ROS)及单核细胞化学吸引蛋白质1(MCP-1)mRNA、蛋白表达的抑制作用,并探讨相......
Growth Inhibiton of H uman Breast Cancer Cell Line MDA-MB-231 by Rosiglitazone through Activation of
To investigate the anti-proliferative effect ofrosiglitazone and its relationship to peroxisome proliferator-activated r......
Rosiglitazone inhibits expression of acyl-coenzyme A:cholesterol acyltransferase-1 in THP-1 macropha
Objective: To investigate the effects of rosiglitazone, a synthetic ligand of peroxisome proliferators-activated recepto......
目的 探讨罗格列酮对高脂饮食性非酒精性脂肪性肝炎(NASH)大鼠的保护作用及其部分机制.方法 30只雄性SD大鼠以掷硬币法均分为正常......
目的观察纤溶酶原激活物抑制剂－1(PAI－1)在罗格列酮抑制大鼠胚肺成纤维细胞转化及胶原合成中的作用及信号机制。方法大鼠胚肺成纤维......
Role and mechanism of rosiglitazone on the impairment of insulin secretion induced by free fatty aci
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生......
A new look at auranoifn, dextromethorphan and rosiglitazone for reduction of glia-mediated inlfammat
Neurodegenerative disorders including Alzheimer’s disease are characterized by chronic in-lfammation in the central ner......
目的:观察结缔组织生长因子(CTGF)在两肾一夹高血压大鼠肾间质中的表达及其与肾损害的关系,探讨罗格列酮对CTGF在肾间质表达的影响......
Summary: The effect of rosiglitazone as the ligand of peroxisome proliferator-activated receptorγ (PPARγ) inhibiting t......
过氧化物酶体增殖物激活受体γ(PPAR γ)是一种由配体激活的核转录因子,其作用广泛,与肝纤维化也存在密切联系[1].本实验选择PPAR ......
Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2
Objective We designed a multi-center, double-blind, randomized, parallel, with metformin controlled clinical trial to ev......
Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor γ a
As a ligand-dependent transcriptional factor, peroxisome proliferator-activated receptor (PPAR) γ was expressed in sev......
Rosiglitazone reduces fatty acid translocase and increases AMPK in skeletal muscle in aged rats: a p
Background As an agonist of peroxisome proliferator-activated receptor-gamma (PPARy), rosiglitazone can prevent acute fa......
Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitaz
Background The difference of cardiovascular effects between rosiglitazone and pioglitazone treatment for diabetic patien......
Growth Inhibiton of H uman Breast Cancer Cell Line MDA-MB-231 by Rosiglitazone through Activation of
To investigate the anti-proliferative effect ofrosiglitazone and its relationship to peroxisome proliferator-activated r......
目的 探讨罗格列酮(ROSI)静脉给药对大鼠重症急性咦腺炎(SAP)的作用及其机制. 方法 雄性Wistar大鼠54只,随机分为假手术组(SO组)、......
目的 探讨过氧化物酶体增殖物激活受体-γ(peroxisomeproliferator-activated receptors-γ,PPAR-y)激动剂罗格列酮(rosiglitazone......
目的探讨罗格列酮(ROSI)对伴高脂血症大鼠重症急性胰腺炎(SAP)肺损伤的保护作用及其可能机制。方法雄性SD大鼠120只，脂肪乳剂灌胃两......
目的探讨罗格列酮对高原肺水肿大鼠的保护作用。方法将36只SD大鼠随机(随机数字法)分为6组：对照组(Control)、低压低氧模型组(HH)、......
目的 通过观察罗格列酮干预前后哮喘小鼠肺组织中GABAARα、MUC5AC表达水平及改变, 初步探讨罗格列酮、GABAARα、MUC5AC三者之间......
Rosiglitazone enhances 5-fluorouracil-induced cell growth inhibition in hepatocellular carcinoma cel
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
噻唑烷二酮类药物是目前治疗糖尿病的主要药物之一,该类药物可增强机体胰岛素敏感性,降低胰岛素抵抗,在降糖效果上与磺脲类和二甲......
目的 观察罗格列酮对联合使用磺脲类、双胍类而血糖控制不好的老年2型糖尿病患者的疗效.方法 对97例联合使用磺脲类、双胍类而血糖......
目的 探讨急性环孢素肾病(ACN)中肾脏乙酰肝素酶(HPA)的表达及罗格列酮(RGZ)对ACN的保护作用.方法 低盐基础上建立ACN大鼠动物模型......
目的 探讨罗格列酮联合胰岛素治疗2型糖尿病合并肺结核的疗效.方法 对2型糖尿病合并肺结核66例患者在常规抗痨治疗的基础上,根据联......
目的观察罗格列酮治疗2型糖尿病患者在改善胰岛素抵抗方面的疗效。方法对10例血糖控制满意的2型糖尿病患者，采用评价胰岛素敏感性金......
目的 研究罗格列酮(ROS)对2型糖尿病患者血清抵抗素(resistin)水平的影响.方法 选择初诊2型糖尿病患者56例,随机分为治疗组36例,对......
目的 观察罗格列酮对糖尿病大鼠肾脏组织病理改变的影响并探讨其作用机制.方法 24只SD大鼠随机分成3组,糖尿病组:腹腔注射含链酶佐......
目的 观察过氧化物酶体增殖物活化受体γ(PPARγ)配体罗格列酮(RSG)对支气管哮喘(哮喘)大鼠气道哮喘发作潜伏期的影响.方法 SD大鼠......
目的 探讨急性环孢素A(CsA)肾毒性肾组织中调节激活正常T细胞表达和分泌的细胞因子(RANTES)及基质金属蛋白酶-9(MMP-9)的表达,以及......
Effect of Rosiglitazone on Endocrine, Metabolism and Ovulatory Performance in Patients with Polycyst
The effect of rosiglitazone on endocrine, metabolism and ovulatory performance in the paitents with polycystic ovary syn......
目的：探讨胰岛素增敏剂罗格列酮及糖尿病健康教育对糖尿病患者血糖控制的影响。方法：60例2型糖尿病患者，对其在应用罗格列酮和系统健......
目的 观察胰岛素增敏剂罗格列酮干预糖耐量减低(IGT)的效果.方法 采用随机对照试验,试验组(80例)给予强化生活方式干预(饮食控制、......
EFFECT OF ROSIGLITAZONE AND METFORMIN ON CLOMIPHENE CITRATE RESISTANCE IN WOMEN WITH POLYCYSTIC OVAR
Objective To evaluate the impacts of rosiglitazone and metformin on ovarian response, hirsutism and insulin action in wo......
目的观察罗格列酮治疗对伴早期肾病的2型糖尿病患者血转化生长因子β1(TGF-β1)的影响。方法 52例早期糖尿病肾病(DN)患者随机分为......
目的 研究罗格列酮联用二甲双胍治疗2型糖尿病的疗效. 方法 将160例2型糖尿病患者随机分为对照组和治疗组.对照组80例口服二甲双胍......
目的 观察罗格列酮预防非酒精性脂肪性肝炎(NASH)大鼠肝纤维化的作用.方法 建立SD大鼠NASH伴肝纤维化的模型(HF24W),同时高脂喂养......
糖耐量受损(IGT)患者治疗3个月后,单服罗格列酮患者血糖、胰岛素、稳态模型胰岛素抵抗指数(HOMA-IR)显著降低,同时减重治疗的患者......
Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2
Objective We designed a multi-center, double-blind, randomized, parallel, with metformin controlled clinical trial to ev......
